• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 305

Carnobacterium maltaromaticum strain CB1 (viable and heat-treated)

Intended Use: Inhibitor of Listeria monocytogenes in a variety of foods including meat and poultry as follows: (1) viable C. maltaromaticum CB1 in ready-to-eat meat products; meat, poultry, and fish products; frozen meals; processed fruit salads and vegetable salads; sauces; and, soft cheese and cheese spread-type products and (2) heat-treated C. maltaromaticum CB1 as an inhibitor of L. monocytogenes in ready-to-eat meat products, meat, poultry, fish, and mixtures; fruits and vegetables; soups and stews; sauces and dressings; and, cheese and cheese spread-type products
Basis: Scientific procedures
Notifier: Griffith Laboratories
Notifier Address: 757 Pharmacy Avenue
Toronto, Ontario
Date of filing: Oct 15, 2009
GRAS Notice (releasable information): GRN 305 (in PDF)
Date of closure: Apr 19, 2010
FDA's Letter: FDA has no questions
Notes: Additional uses in GRN 159